Heart Disease News and Research

Latest Heart Disease News and Research

Short-term exercise has a significant impact on insulin action in overweight people

Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.

7 Oct 2004

Statistics reveal that there are now 1.8 million people with diabetes in the UK

New statistics revealed by Diabetes UK show that there are now 1.8 million people with diabetes in the UK – three per cent of the population, equivalent to the combined population of Liverpool, Birmingham and Manchester.

7 Oct 2004

Lipid profile differences explain why two people with the same overall cholesterol level can have different degrees of cardiovascular disease

When it comes to lipid profiles -- a key measure of heart disease risk-- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.

7 Oct 2004

Breast cancer drug Taxotere extends life of prostate cancer patients

Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy

6 Oct 2004

Transatlantic study to help damaged hearts repair themselves

A $6 million, five-year grant from the Parisian Fondation Leduq has set up a transatlantic effort to study ways to help damaged hearts repair themselves, using stem cells from bone marrow, bloodstream, and adult heart tissue.

6 Oct 2004

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments so that kids are less likely to develop heart problems or second malignancies later, as a result of radiation therapy.

6 Oct 2004

Women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease

A new position statement issued today by the American Association of Clinical Endocrinologists (AACE) states that women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease.

6 Oct 2004

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

A recent nationally representative survey of older adults finds that 18 percent of those with chronic conditions such as heart disease and depression skip some of their prescription medicines because of out-of-pocket cost pressures, and 14 percent do so at least every month.

6 Oct 2004

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Indiana State health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine to immunizing people at high risk from complications of influenza.

6 Oct 2004

Understanding how microbes in the gut interact with the body could lead to new a understanding and novel treatments for diseases

Understanding how microbes in the gut interact with the body could lead scientists and doctors to new a understanding and novel treatments for diseases say scientists from Imperial College London and Astra Zeneca.

6 Oct 2004

Low-fat meals reduce effectiveness of vitamin E supplementation

Research at the University of Surrey has now shown that if a vitamin E supplement is taken with a low-fat meal, the absorption of the vitamin into the blood stream, and therefore its efficacy, is significantly reduced.

6 Oct 2004

Discovery of the oldest remains of a woman who died in childbirth

In ancient times, female death rates were particularly high and generally related to problems in maternity, such as complications during pregnancy, childbirth or the period of breast-feeding.

6 Oct 2004

EMEA statement following withdrawal of Vioxx (rofecoxib)

EU regulators met with the marketing authorisation holder of Vioxx (rofecoxib), Merck Sharp & Dohme, on 4-5 October 2004 at the informal meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) held in Scheveningen, The Netherlands.

6 Oct 2004

Heart Disease News and Research

Latest Heart Disease News and Research

Short-term exercise has a significant impact on insulin action in overweight people

Statistics reveal that there are now 1.8 million people with diabetes in the UK

Lipid profile differences explain why two people with the same overall cholesterol level can have different degrees of cardiovascular disease

Breast cancer drug Taxotere extends life of prostate cancer patients

Transatlantic study to help damaged hearts repair themselves

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

Women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Understanding how microbes in the gut interact with the body could lead to new a understanding and novel treatments for diseases

Low-fat meals reduce effectiveness of vitamin E supplementation

Discovery of the oldest remains of a woman who died in childbirth

EMEA statement following withdrawal of Vioxx (rofecoxib)

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Noncardiac surgery risky for older heart failure patients

Surgery to reshape damaged hearts may provide long-term benefits for certain patients with advanced heart failure

Testosterone may help men recover from a stroke

Patients suffering from diseases as varied as Type II diabetes, Alzheimer's, Parkinson's have one thing in common

Research continues to show the cardiovascular benefits of fish consumption or omega-3 fatty acids

U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Heart Disease News and Research

Latest Heart Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in